Neuroprotection achieved in the ischaemic rat cortex with l-kynurenine sulphate

Hermina Robotka, Katalin Sas, Márta Ágoston, Éva Rózsa, Gábor Szénási, Gábor Gigler, László Vécsei, József Toldi

Research output: Contribution to journalArticle

31 Citations (Scopus)


l-Kynurenine is a metabolic precursor of kynurenic acid, which is one of the few known endogenous N-methyl-d-aspartate receptor inhibitors. In contrast with kynurenic acid, l-kynurenine is transported across the blood-brain barrier, and it may therefore come into consideration as a therapeutic agent in certain neurobiological disorders, e.g. ischaemia-induced events. The present study evaluated the effect of l-kynurenine administration (300 mg/kg i.p.) on the global ischaemic brain cortex both pre- and post-ischemic intervention. The statistical evaluation revealed that l-kynurenine administration beneficially decreased the number of neurones injured per mm2 in the cortex, not only in the pre-treated animals, but also in those which received l-kynurenine after the ischaemic insult. It is concluded that even the post-traumatic administration of l-kynurenine may be of substantial therapeutic benefit in the treatment of global brain ischaemia. This is the first histological proof of the neuroprotective effect achieved by the post-traumatic administration of l-kynurenine in the global ischaemic cortex.

Original languageEnglish
Pages (from-to)915-919
Number of pages5
JournalLife Sciences
Issue number17-18
Publication statusPublished - Apr 23 2008


  • Fluoro-Jade B
  • Global ischaemia
  • Kynurenic acid
  • Kynurenine
  • Neuroprotection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Neuroprotection achieved in the ischaemic rat cortex with l-kynurenine sulphate'. Together they form a unique fingerprint.

  • Cite this